State Key Laboratory of Bioelectronics, Jiangsu Key Laboratory for Biomaterials and Devices, School of Biological Science and Medical Engineering, Southeast University, Nanjing 210096, PR China; Collaborative Innovation Center of Suzhou Nano Science and Technology, Suzhou 215123, PR China.
State Key Laboratory of Bioelectronics, Jiangsu Key Laboratory for Biomaterials and Devices, School of Biological Science and Medical Engineering, Southeast University, Nanjing 210096, PR China; Materials Science and Devices Institute, Suzhou University of Science and Technology, 1 Kerui Road, Suzhou, Jiangsu 215009, PR China.
Biochim Biophys Acta Gen Subj. 2019 Feb;1863(2):502-510. doi: 10.1016/j.bbagen.2018.12.002. Epub 2018 Dec 6.
Magnetic nanoparticles (MNPs) have been widely used in biomedical applications. Proper control of the duration of MNPs in circulation promises to improve further their applications, in particularly drug delivery. It is known that the uptake of tissue-associated MNPs is mainly carried out by macrophages. Yet, the molecular mechanism to control MNPs internalization in macrophages remains to be elusive. Missing-in-metastasis (MIM) is a scaffolding protein that is highly expressed in macrophages and regulates receptor-mediated endocytosis. We hypothesize that uptake of MNPs may also involve the function of MIM.
We investigated the effect of MIM expression on the intracellular trafficking of MNPs by transmission electronic microscopy, flow cytometry, o-phenanthroline photometric analysis, Perl's staining, immunofluorescence microscopy and co-immunoprecipitation. To explore the molecular events in MIM-mediated MNPs uptake, we examined the effect of MNPs on the interaction of MIM with clathrin, Rab5 and Rab7.
Uptake of MNPs was significantly enhanced in cells overexpressing MIM. Upon exposure to MNPs, MIM was associated with clathrin light chain in endocytic vesicles and Rab7, a protein that regulates late endosomes. However, MNPs caused dissociation of MIM with Rab5, an early endosome-associated protein.
MIM regulates internalization of MNPs via promoting their trafficking from plasma membrane to late endosomes.
Our data unveiled a novel pathway which MNPs internalization and intracellular trafficking in macrophages. This new pathway may allow us to control the uptake of MNPs within cells by targeting MIM, thereby improving their medical applications.
磁性纳米颗粒(MNPs)已广泛应用于生物医学领域。适当控制 MNPs 在循环中的持续时间有望进一步提高其应用,特别是在药物输送方面。已知组织相关 MNPs 的摄取主要由巨噬细胞完成。然而,控制巨噬细胞内 MNPs 内化的分子机制仍不清楚。缺失转移(MIM)是一种支架蛋白,在巨噬细胞中高度表达,调节受体介导的内吞作用。我们假设 MNPs 的摄取也可能涉及 MIM 的功能。
我们通过透射电子显微镜、流式细胞术、邻菲啰啉光密度分析、Perl 染色、免疫荧光显微镜和共免疫沉淀研究了 MIM 表达对 MNPs 细胞内转运的影响。为了探讨 MIM 介导的 MNPs 摄取中的分子事件,我们研究了 MNPs 对 MIM 与网格蛋白、Rab5 和 Rab7 相互作用的影响。
在过表达 MIM 的细胞中,MNPs 的摄取明显增强。暴露于 MNPs 后,MIM 与网格蛋白轻链在内吞小泡中以及调节晚期内体的蛋白 Rab7 相关。然而,MNPs 导致 MIM 与早期内体相关蛋白 Rab5 解离。
MIM 通过促进 MNPs 从质膜向晚期内体的转运来调节 MNPs 的内化。
我们的数据揭示了一个新的途径,即 MNPs 在巨噬细胞中的内化和细胞内转运。通过靶向 MIM,这种新途径可以控制细胞内 MNPs 的摄取,从而提高它们的医学应用。